These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 20858622)

  • 21. Unresolved issue: should patients with RA and a history of malignancy receive anti-TNF therapy?
    Brar A; Hiebert T; El-Gabalawy H
    Nat Clin Pract Rheumatol; 2007 Mar; 3(3):120-1. PubMed ID: 17334334
    [No Abstract]   [Full Text] [Related]  

  • 22. Etanercept: anti-tumor necrosis factor therapy for rheumatoid arthritis.
    McGahan L
    Issues Emerg Health Technol; 1999 Oct; (8):1-6. PubMed ID: 11811215
    [No Abstract]   [Full Text] [Related]  

  • 23. Anti-tumor necrosis factor alpha switching in rheumatoid arthritis and juvenile chronic arthritis.
    Favalli EG; Arreghini M; Arnoldi C; Panni B; Marchesoni A; Tosi S; Pontikaki I
    Arthritis Rheum; 2004 Apr; 51(2):301-2. PubMed ID: 15077278
    [No Abstract]   [Full Text] [Related]  

  • 24. Heart failure in rheumatoid arthritis: rates, predictors, and the effect of anti-tumor necrosis factor therapy.
    Wolfe F; Michaud K
    Am J Med; 2004 Mar; 116(5):305-11. PubMed ID: 14984815
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Herpes zoster encephalomyelitis in a patient with rheumatoid arthritis treated with low dose methotrexate.
    Golden HE
    J Rheumatol; 1997 Dec; 24(12):2487-8. PubMed ID: 9415667
    [No Abstract]   [Full Text] [Related]  

  • 26. TNF antagonists and shingles: is vaccination advisable?
    Nisar MK; Ostor AJ
    Ann Rheum Dis; 2013 May; 72(5):e1. PubMed ID: 23456927
    [No Abstract]   [Full Text] [Related]  

  • 27. Detection of tuberculosis by extensive screening in a patient with rheumatoid arthritis prior to anti-TNF-alpha therapy.
    Iseli A; Hüllstrung HD; Rodenhausen S; Widmer AF; Tyndall A; Hasler P
    Rheumatology (Oxford); 2006 Aug; 45(8):1049-50. PubMed ID: 16769772
    [No Abstract]   [Full Text] [Related]  

  • 28. Indolent infectious tenosynovitis afflicting rheumatoid patients treated with tumor necrosis factor inhibitors: case report.
    Abrams R; Savoia M; Vinetz J; Dacus AR
    J Hand Surg Am; 2010 Jun; 35(6):909-12. PubMed ID: 20350799
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Anti-cyclic citrullinated peptide antibodies in patients with rheumatoid arthritis treated with anti-tumour necrosis factor agents.
    Russell AS; Maksymowych WP; de Silva M
    Ann Rheum Dis; 2005 Dec; 64(12):1807. PubMed ID: 16284357
    [No Abstract]   [Full Text] [Related]  

  • 30. Demyelinating and neurologic events reported in association with tumor necrosis factor alpha antagonism: by what mechanisms could tumor necrosis factor alpha antagonists improve rheumatoid arthritis but exacerbate multiple sclerosis?
    Robinson WH; Genovese MC; Moreland LW
    Arthritis Rheum; 2001 Sep; 44(9):1977-83. PubMed ID: 11592357
    [No Abstract]   [Full Text] [Related]  

  • 31. Primary cutaneous Nocardia otitidiscaviarum infection in a patient with rheumatoid arthritis treated with infliximab.
    Fabre S; Gibert C; Lechiche C; Jorgensen C; Sany J
    J Rheumatol; 2005 Dec; 32(12):2432-3. PubMed ID: 16331777
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Impact of anti-tumour necrosis factor therapy on the weight of patients with rheumatoid arthritis.
    Alcorn N; Tierney A; Wu O; Gilmour H; Madhok R
    Ann Rheum Dis; 2010 Aug; 69(8):1571. PubMed ID: 20388741
    [No Abstract]   [Full Text] [Related]  

  • 33. Infection and musculoskeletal conditions: Bacterial and opportunistic infections during anti-TNF therapy.
    Strangfeld A; Listing J
    Best Pract Res Clin Rheumatol; 2006 Dec; 20(6):1181-95. PubMed ID: 17127203
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Reactivation of brucellosis after treatment with infliximab in a patient with rheumatoid arthritis.
    Jiménez FG; Colmenero JD; Irigoyen MV
    J Infect; 2005 May; 50(4):370-1. PubMed ID: 15845443
    [No Abstract]   [Full Text] [Related]  

  • 35. Perforating folliculitis associated with tumour necrosis factor-alpha inhibitors administered for rheumatoid arthritis.
    Gilaberte Y; Coscojuela C; Vázquez C; Roselló R; Vera J
    Br J Dermatol; 2007 Feb; 156(2):368-71. PubMed ID: 17223880
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Management of rheumatoid arthritis.
    Handa R
    Natl Med J India; 2004; 17(3):143-51. PubMed ID: 15253402
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [TNF-alpha blockers, rheumatoid arthritis and pulmonary tuberculosis].
    Mihăltan F
    Pneumologia; 2007; 56(4):212-6. PubMed ID: 18320798
    [No Abstract]   [Full Text] [Related]  

  • 38. Primary nasal tuberculosis during anti-tumour necrosis factor alpha treatment of a patient with rheumatoid arthritis.
    Ribeiro S; Ferreira B; Duarte R; Almeida I; Vasconcelos C
    Scand J Infect Dis; 2013 Dec; 45(12):957-60. PubMed ID: 23957541
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Anti-tumor necrosis factor-alpha therapy provokes latent leishmaniasis in a patient with rheumatoid arthritis.
    Franklin G; Greenspan J; Chen S
    Ann Clin Lab Sci; 2009; 39(2):192-5. PubMed ID: 19429808
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Biologic therapy for rheumatoid arthritis.
    Klippel JH
    N Engl J Med; 2000 Nov; 343(22):1640-1. PubMed ID: 11096174
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.